95 related articles for article (PubMed ID: 1746777)
1. Successful use of subcutaneous recombinant human erythropoietin before cholecystectomy in an anemic patient with religious objections to transfusion therapy.
Fletcher JL; Perez JC; Jones DH
Am Surg; 1991 Nov; 57(11):697-700. PubMed ID: 1746777
[TBL] [Abstract][Full Text] [Related]
2. [Recombinant erythropoietin in autologous blood donation].
von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant human erythropoietin (epoetin) and autologous blood transfusion in chronic hemodialysis. Apropos of 2 cases].
Montagnac R; Ebikili B; Schillinger F
Nephrologie; 1997; 18(1):23-6. PubMed ID: 9121601
[TBL] [Abstract][Full Text] [Related]
4. [Clinical applications of erythropoietin].
Robak T
Acta Haematol Pol; 1994; 25(2 Suppl 1):112-23. PubMed ID: 8067196
[TBL] [Abstract][Full Text] [Related]
5. Use of human recombinant erythropoietin to correct severe preoperative anemia.
Fullerton DA; Campbell DN; Whitman GJ
Ann Thorac Surg; 1991 May; 51(5):825-6. PubMed ID: 2025094
[TBL] [Abstract][Full Text] [Related]
6. [Administration of recombinant erythropoietin to a patient with malignant lymphoma who refused blood transfusion].
Ushijima A; Nishimura H; Kawakita M; Takatsuki K
Rinsho Ketsueki; 1990 Oct; 31(10):1698-700. PubMed ID: 2255059
[TBL] [Abstract][Full Text] [Related]
7. Autologous blood donation with recombinant human erythropoietin in cardiac surgery: the Japanese experience.
Baron JF
Semin Hematol; 1996 Apr; 33(2 Suppl 2):64-7; discussion 68. PubMed ID: 8723586
[TBL] [Abstract][Full Text] [Related]
8. Use of recombinant human erythropoietin to enhance autologous blood donation in a patient with multiple red cell allo-antibodies and the anemia of chronic disease.
Thompson FL; Powers JS; Graber SE; Krantz SB
Am J Med; 1991 Mar; 90(3):398-400. PubMed ID: 2003523
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of treating anemia in patients undergoing chronic dialysis with small doses of human recombinant erythropoietin].
Marusza W; Matuszkiewicz-Rowińska J; Tomik Z; Andrzejewski A; Rokicka M; Paszkowska M; Drygieniec D; Bobilewicz D; Zawadzka M; Abbas-Fatah A
Pol Tyg Lek; 1995 Oct; 50(40-44):15-8, 31. PubMed ID: 8650050
[TBL] [Abstract][Full Text] [Related]
10. Extended hemipelvectomy in a Jehovah's Witness with erythropoietin support.
Meyers MO; Heinrich S; Kline R; Levine EA
Am Surg; 1998 Nov; 64(11):1074-6. PubMed ID: 9798772
[TBL] [Abstract][Full Text] [Related]
11. [Recombinant human erythropoietin (KRN5702) therapy for autologous blood transfusion in patients with rheumatoid arthritis undergoing joint replacement surgery--a multicenter phase II clinical trial].
Saikawa I; Sugioka Y; Hotokebuchi T; Tsutsui H; Inaba S; Takagishi K; Iwata H; Ogawa R; Kondo M; Ogata K
Ryumachi; 1994 Jun; 34(3):583-93. PubMed ID: 8052924
[TBL] [Abstract][Full Text] [Related]
12. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
Marques da Costa R
Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anemia of chronic disease.
Salvarani C; Lasagni D; Casali B; Macchioni P; Boiardi L; Rossi F; Rivasi P; Portioli I
J Rheumatol; 1991 Aug; 18(8):1168-71. PubMed ID: 1941817
[TBL] [Abstract][Full Text] [Related]
14. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
Zehnder C; Blumberg A
Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
[TBL] [Abstract][Full Text] [Related]
15. The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation.
Goodnough LT; Verbrugge D; Marcus RE; Goldberg V
J Am Coll Surg; 1994 Aug; 179(2):171-6. PubMed ID: 8044386
[TBL] [Abstract][Full Text] [Related]
16. Peri-operative use of recombinant human erythropoietin in Jehovah's Witnesses.
Bourantas KL; Xenakis TA; Hatzimichael EC; Kontogeorgakos V; Beris AE
Haematologica; 2000 Apr; 85(4):444-5. PubMed ID: 10756382
[No Abstract] [Full Text] [Related]
17. Jehovah's Witnesses: unique problems in a unique trauma population.
Victorino G; Wisner DH
J Am Coll Surg; 1997 May; 184(5):458-68. PubMed ID: 9145065
[TBL] [Abstract][Full Text] [Related]
18. Preoperative recombinant human erythropoietin in anemic surgical patients.
Monk TG
Crit Care; 2004; 8 Suppl 2(Suppl 2):S45-8. PubMed ID: 15196324
[TBL] [Abstract][Full Text] [Related]
19. The use of recombinant human erythropoietin in a Jehovah's Witness requiring major reconstructive surgery.
Connor JP; Olsson CA
J Urol; 1992 Jan; 147(1):131-2. PubMed ID: 1729504
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
